- Home
- NBIX vs CSL Comparison
NBIX vs CSL Comparison
Compare NBIX & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | CSL |
|---|---|---|
| Founded | 1992 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 13.4B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | CSL |
|---|---|---|
| Price | $142.31 | $332.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | $176.19 | ★ $386.67 |
| AVG Volume (30 Days) | ★ 977.3K | 439.3K |
| Earning Date | 02-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 1.33% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | 4.19 | ★ 17.56 |
| Revenue | $2,682,700,000.00 | ★ $5,015,100,000.00 |
| Revenue This Year | $23.76 | $1.01 |
| Revenue Next Year | $18.01 | $2.69 |
| P/E Ratio | $33.80 | ★ $18.81 |
| Revenue Growth | ★ 19.61 | 0.14 |
| 52 Week Low | $84.23 | $293.43 |
| 52 Week High | $160.18 | $435.92 |
Technical Indicators
Market Signals| Indicator | NBIX | CSL |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 58.74 |
| Support Level | $151.09 | $327.60 |
| Resistance Level | $155.55 | $338.15 |
| Average True Range (ATR) | 4.52 | 8.06 |
| MACD | -1.41 | 1.71 |
| Stochastic Oscillator | 5.75 | 69.77 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CSL Carlisle Companies Incorporated
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.